HR (95% CI; P) | |||||
---|---|---|---|---|---|
Salivary glands | Ears | TMJS | Skin | Subcutaneous soft tissue | |
Gender | 0.911 (0.439-1.890) | 1.015 (0.983-1.049) | 1.766 (0.508-6.141) | 0.759 (0.376-1. 53) | 6.046 (0.775-47.153) |
P > 0.05 | P > 0.05 | P > 0.05 | P > 0.05 | P > 0.05 | |
Age | 0.987 (0.959-1.017) | 3.311 (1.322-8.288) | 1.035 (0.983-1.089) | 0.994 (0.967-1.022) | 1.005 (0.957-1.054) |
P > 0.05 | P = 0.011 | P > 0.05 | P > 0.05 | P > 0.05 | |
Stage (I-II vs III-IV) | 1.455 (0.673-3.143) | 1.919 (0.833-4.42) | 2.511 (0.462-13.656) | 0.720 (0.336-1.54) | 2.081 (0.596-7.267) |
P > 0.05 | P > 0.05 | P > 0.05 | P > 0.05 | P > 0.05 | |
T Stage (T1-2vs T3-4) | 0.977 (0.454-2.101) | 0.926 (0.400-2.144) | 2.496 (0.469-13.280) | 1.759 (0.831-3.727) | 0.776 (0.230-2.618) |
P > 0.05 | P > 0.05 | P > 0.05 | P > 0.05 | P > 0.05 | |
Radiotherapy vs Chemoradiotherapy | 2.249 (1.186-4.265) | 4.012 (1.839-8.749) | 0.681 (0.211-2.203) | 1.282 (0.682-2.409) | 3.823 (0.998-14.649) |
P = 0.013 | P = 0.000 | P > 0.05 | P > 0.05 | P = 0.050 |